Sustained CD4 responses after virological failure of protease inhibitor-containing therapy

Antiviral Therapy

Volumn 4, Issue SUPPL. 3, 1999, Pages 7-11

  Deeks, Steven G ^a   Grant, Robert M ^a,b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

CLINICAL STUDY; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE COUNT; PRIORITY JOURNAL; RETROVIRUS INFECTION; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; RNA, VIRAL; TREATMENT FAILURE; VIRAL LOAD;

EID: 0032760390     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, Leonard HM, Daner SA, Miedema F & Schellekens PT. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Medicine 1998; 4:208-214.
2. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H & Autran B. Long-lasting recovery in CD4 T-cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351:1682-1686.
3. Komanduri KV, Viswanathan MN, Wieder ED, Schmidt DK, Bredt BM, Jacobson MA &: McCune JM. Restoration of cytomegalovirus-specific CD4+ T lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nature Medicine 1998; 4:953-956.
4. Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA & Saag MS. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. Journal of Infectious Diseases 1998; 177:40-47.
5. Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, Leder T, Berger A, Weidemann E, Hill A & Phillips A. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS 1999; 13:951-956.